Professional integrity in clinical research

JAMA

Volumn 280, Issue 16, 1998, Pages 1449-1454

  Miller, Franklin G ^a,c   Rosenstein, Donald L ^b   DeRenzo, Evan G ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DOCTOR PATIENT RELATION; MEDICAL EDUCATION; MEDICAL ETHICS; MORALITY; PHYSICIAN; PRIORITY JOURNAL;

EID: 0032576111     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.16.1449     Document Type: Article

References (30)

1. Beecher HK. Ethics and clinical research. N Engl J Med. 1966;274:1354-1360.
2. Rothman DJ. Strangers at the Bedside. New York, NY: Basic Books; 1991:70-84.
3. Faden R, Beauchamp TL. A History and Theory of Informed Consent. New York, NY: Oxford University Press; 1986:200-232.
4. Schwartz J. Company faulted in fatal drug trials. Washington Post. December 10, 1993:A4.
5. McGinley L. FDA finds Lilly, others violated rules in tests of hepatitis drug that killed 5. Wall Street Journal. May 16, 1994:B6.
6. Office for Protection From Research Risks. Evaluation of Human Subject Protections in Schizophrenia Research Conducted by the University of California, Los Angeles. Rockville, Md: Office for Protection From Risks, National Institutes of Health; 1994.
7. Haimowitz S, Delano SJ, Oldham JM. Uninformed decisionmaking: the case of surrogate research consent. Hastings Cent Rep. 1997;27(6):9-16.
8. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1997;338:101-106.
9. Rules and Regulations. Rockville, Md: US Dept Health and Human Services; 1991. Publication 45CFR46.
10. Advisory Committee on Human Radiation Experiments. Final Report. Washington, DC: US Government Printing Office; 1995:797-798.
11. Miller FG, Caplan AL, Fletcher JC. Dealing with Dolly: inside the National Bioethics Advisory Commission. Health Affairs (Millwood). 1998;17:264-267.
12. Lind SE Financial issues and incentives related to clinical research and innovative therapies. In: Vanderpool HY, ed. The Ethics of Research Involving Human Subjects. Frederick, Md: University Publishing Group; 1996:185-202.
13. Miller FG, Brody H. Professional integrity and physician-assisted death. Hastings Cent Rep. 1995;25(3):8-17.
14. Reiser SJ. Human experimentation and the convergence of medical research and patient care. In: Bernard Barber, ed. Medical Ethics and Social Change. Philadelphia, Pa: American Academy of Political and Social Science; 1978.
15. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987;17(2):20-24.
16. Festinger LA. Theory of Cognitive Dissonance. Evanston, Ill: Row Peterson; 1957.
17. Lipsett MB. On the nature and ethics of phase I clinical trials of cancer chemotherapies. JAMA. 1982;248:941-942.
18. Freedman B. The ethical analysis of clinical trials: new lessons for and from cancer research. In: Vanderpool HY, ed. The Ethics of Research Involving Human Subjects. Frederick, Md: University Publishing Group; 1996:319-338.
19. Carpenter WT, Schooler NR, Kane JM. The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry. 1997;54:401-407.
20. Schulz KF. Subverting randomization in controlled trials. JAMA. 1995;274:1456-1458.
21. Katz J. Human experimentation and human rights. St Louis University Law Journal. 1993;38:7-54.
22. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995;13:1062-1072.
23. Kass NE, Sugarman J, Faden R, Schoch-Spana M. Trust: the fragile foundation of contemporary biomedical research. Hastings Cent Rep. 1996;26(5):25-29.
24. Schwartz J. Final Report of the Attorney General's Research Working Group Baltimore, Md: Office of the Maryland Attorney General; June 12, 1998.
25. Levine RJ. Ethics and Regulation of Clinical Research. 2nd ed. New Haven, Conn: Yale University Press; 1986:8-10.
26. Miller FG, Rosenstein DL. Psychiatric symptom-provoking studies: an ethical appraisal. Biol Psychiatry. 1997;42:403-409.
27. Grinnell F. Ending of clinical research protocols: distinguishing therapy from research. IRB. 1992;12:1-3.
28. Shorter E. A History of Psychiatry. New York, NY: John Wiley & Sons; 1997:141-142.
29. Pellegrino ED, Thomasma DC. A Philosophical Basis of Medical Practice. New York, NY: Oxford University Press; 1981:151-152.
30. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for Research Involving Human Subjects. Washington, DC: US Government Printing Office; 1979.